Последнее обновление :
08/05/2024
Цитостатическое средство   Dactinomycin  
Инъекция
Стабильность растворов Стабильность смесей Факторы, которые влияют на стабильность Совместимость Способы введения Библиография Pdf
   Химическая структура  

Товарное название   Товарное название     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cosmegen Австралия, Австрия, Аргентина, Греция, Иран, Италия, Канада, Малайзия, Мексика, новая Зеландия, Норвегия, Соединённые Штаты Америки, Финляндия, Франция, Швейцария, Швеция
Cosmegen Lyovac Великобритания, Ирландия, Румыния
Dacilon Индия, Перу, чили
Dacmozen Индия
Dactino Индия
Dactinomicina Колумбия, Перу, чили, Эквадор
Dactinomycin новая Зеландия
Lyovac Cosmegen Бельгия, Германия, Голландия, Люксембург
Библиография   Инъекция   Библиография : Dactinomycin  
тип публикация
3 Журнал Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
84 Журнал Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
99 Журнал Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
169 Журнал Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182 Журнал Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244 Журнал Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
249 Журнал Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
307 Журнал Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
334 Журнал Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335 Журнал Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
492 Журнал Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
729 Журнал Rusmin S, Welton S, DeLuca P, DeLuca PP.
Effect of inline filtration on the potency of drugs administered intravenously.
Am J Hosp Pharm 1977 ; 34: 1071-1074.
857 Журнал Kanke M, Eubanks JL, DeLuca PP.
Binding of selected drugs to a “treated” inline filter.
Am J Hosp Pharm 1983 ; 40: 1323-1328.
905 Журнал Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
1178 Журнал Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL.
Stability and compatibility of antitumor agents in glass and plastic containers.
Am J Hosp Pharm 1981 ; 38: 1914-1918.
1322 Журнал Ennis CE, Merritt RJ, Neff DN.
In vitro study of inline filtration of medications commonly administered to pediatric cancer patients.
JPEN 1983 ; 7: 156-158.
1410 Журнал Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1423 Журнал Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
4153 Лаборатория Dactinomycin (Cosmegen Lyovac®) - Summary of Product Characteristics
Orphan Europe (UF) Limited 2014

  Mentions Légales